As filed with the Securities and Exchange Commission on June 18, 2004 Registration No. (333- ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------- FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ------------------- TRANSACT TECHNOLOGIES INCORPORATED (Exact name of registrant as specified in its charter) Delaware 06-1456680 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 7 Laser Lane Wallingford, Connecticut 06492 (203) 269-1198 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) Steven A. DeMartino Executive Vice President, Chief Financial Officer, Secretary and Treasurer TransAct Technologies Incorporated 7 Laser Lane Wallingford, Connecticut 06492 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Edward M. Kane, Esq. Shipman & Goodwin LLP 300 Atlantic Street Stamford, Connecticut 06901 (203) 324-8100 Approximate date of commencement of proposed sale of the securities to the public: From time to time after this Registration Statement becomes effective. If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [ ] If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following box. [X] If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement number of the earlier effective registration statement for the same offering. [ ] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [ ] CALCULATION OF REGISTRATION FEE TITLE OF EACH PROPOSED PROPOSED CLASS OF MAXIMUM MAXIMUM SECURITIES TO BE AMOUNT TO BE OFFERING PRICE AGGREGATE AMOUNT OF REGISTERED REGISTERED (1) PER SHARE (2) OFFERING PRICE (3) REGISTRATION FEE Common Stock, par value $0.01 per share 666,665 $ 30.645 $ 20,429,948.92 $ 2,588.47 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, the number of shares of Common Stock registered hereby includes an indeterminate number of shares of Common Stock that may be issued in connection with a stock split, stock dividend, recapitalization or similar event. (2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales prices of $31.50 and $29.79 of the Common Stock reported by The Nasdaq SmallCap Market on June 14, 2004. (2) The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission acting pursuant to said Section 8(a), may determine.
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO THE REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE. SUBJECT TO COMPLETION, DATED JUNE 18, 2004 PROSPECTUS TRANSACT TECHNOLOGIES INCORPORATED 666,665 SHARES COMMON STOCK We are registering 666,665 shares of our common stock for offer and sale from time to time by the selling stockholders named in this prospectus. We will not receive any of the proceeds from the sale of these shares of common stock. This prospectus should be read in conjunction with the documents incorporated by reference herein. Our common stock is traded on The Nasdaq SmallCap Market under the symbol "TACT." On June 17, 2004, the last reported sale price of our common stock was $31.79 per share. Investing in our common stock involves risks. See "Risk Factors" beginning on page 5, and the risk factors incorporated herein by reference, for a discussion of the risks you should consider before investing in our common stock. The shares covered by this prospectus may be offered for sale from time to time on The Nasdaq SmallCap Market or otherwise, at prices then obtainable. The selling stockholders listed in this prospectus may sell any, all or none of the shares offered by this prospectus. See "Plan of Distribution" beginning on page 12 for a discussion of these and other distribution matters. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. The date of this prospectus is June [ ], 2004.
TABLE OF CONTENTS PAGE Summary................................................ 3 Risk Factors........................................... 5 Note on Forward-Looking Statements..................... 7 Use of Proceeds........................................ 8 Selling Stockholders................................... 9 Description of Common Stock............................ 10 Plan of Distribution................................... 12 Legal Matters.......................................... 13 Experts................................................ 13 Where You Can Find More Information.................... 14 Incorporation by Reference............................. 14 2
SUMMARY The following summary contains basic information about TransAct Technologies Incorporated and this offering. Because this is a summary, it necessarily does not contain all the information that may be important to you. For a more complete understanding of the offering, we encourage you to read carefully this entire prospectus, including the "Risk Factors" section, and the documents incorporated by reference herein. When we refer to "TransAct," "the Company," "we," "our" and "us" in this prospectus, we mean TransAct Technologies Incorporated and its subsidiaries unless the context indicates otherwise. BUSINESS OF THE COMPANY TransAct was incorporated in June 1996 and began operating as a stand-alone business in August 1996 as a spin-off of the printer business that was formerly conducted by certain subsidiaries of Tridex Corporation. We completed an initial public offering on August 22, 1996. TransAct designs, develops, manufactures and markets transaction-based printers under the Ithaca(R) and Magnetec(R) brand names. In addition, we market related consumables, spare parts and services. Our printers are used worldwide to provide transaction records such as receipts, tickets, coupons, register journals and other documents. We focus on two core markets: (1) point-of-sale and banking ("POS"), and (2) gaming and lottery. We sell our products directly to original equipment manufacturers ("OEMs"), value-added resellers ("VARs"), selected distributors and directly to end-users. Our product distribution spans across the Americas, Europe, the Middle East, Africa, the Caribbean Islands and the South Pacific. Our executive offices are located in Wallingford, Connecticut and we have one primary operating facility located in Ithaca, New York, five sales offices located in the United States, and one sales office and service depot in the United Kingdom. RECENT DEVELOPMENTS On June 2, 2004, we announced the signing of a letter of intent under which TransAct would acquire the transaction printer and printhead business known as TPG, a division of ATSI Holdings Inc. (formerly known as Axiohm Transaction Solutions). Based on the terms described in the letter of intent, the expected purchase price would be approximately $23 million. Our acquisition of the TPG business is subject to several contingencies, including the completion of our due diligence investigation and the negotiation of definitive agreements. We cannot give any assurance that definitive agreements will be successfully negotiated or, even if they are, that they will contain terms that are identical to those contained in the letter of intent or that the transaction will be successfully completed. SELECTED CONSOLIDATED FINANCIAL DATA (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS) The selected financial data set forth below as of December 31, 2003 and 2002, and for the three years ended December 31, 2003, are derived from our financial statements, except for the impact of the stock split described in the following paragraph, which are incorporated herein by reference and which have been audited by PricewaterhouseCoopers LLP, our independent registered public accounting firm. The selected financial data set forth below as of December 31, 2001, 2000 and 1999 and for the two years ended December 31, 2000 are derived from our audited financial statements, except for the impact of the stock split described in the following paragraph, which are not included in this prospectus. On April 2, 2004, we effected a 3-for-2 stock split of our common stock in the form of a 50% stock dividend. We began trading on a split basis on April 5, 2004. All amounts presented in our 2003 Annual Report on Form 10-K incorporated herein by reference do not reflect the stock split. Amounts presented in this prospectus, including the Selected Consolidated Financial Data below, have been adjusted to reflect the stock split. 3
The data set forth below should be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements, including the notes thereto, which are incorporated herein by reference. Year Ended December 31, ------------------------------------------- 2003 2002 2001 2000 1999 ------- ------- ------- ------- ------- Statement of Operations Data: Net sales $52,098 $39,461 $43,974 $53,720 $44,889 Gross profit 15,543 10,216 9,774 14,142 11,754 Operating expenses 12,855 11,200 17,060 14,296 11,719 Operating income (loss) 2,688 (984) (7,286) (154) 35 Net income (loss) 1,528 (692) (4,922) (344) 324 Net income (loss) available to common shareholders 1,170 (1,050) (5,280) (664) 324 Net income (loss) per share: Basic 0.13 (0.12) (0.63) (0.08) 0.04 Diluted 0.13 (0.12) (0.63) (0.08) 0.04 December 31, ------------------------------------------- 2003 2002 2001 2000 1999 ------- ------- ------- ------- ------- Balance Sheet Data: Total assets $26,361 $22,030 $25,791 $27,619 $25,684 Working capital 11,787 8,798 8,366 13,631 11,094 Long-term debt, excluding current portion 330 2,791 5,344 5,944 7,100 Redeemable convertible preferred stock 3,902 3,824 3,746 3,668 - Shareholders' equity 10,347 6,545 7,315 12,191 12,207 THE OFFERING Securities Offered.... 666,665 shares of common stock of TransAct. Use of Proceeds....... The Company will not receive any proceeds from the sale of common stock by the selling stockholders. Capital Stock......... Our common stock is listed on The Nasdaq SmallCap Market under the symbol "TACT." OUR ADDRESS Our executive offices are located at 7 Laser Lane, Wallingford, Connecticut 06492 and our telephone number is (203) 269-1198. Our website is located at www.transact-tech.com. The information on our website is not part of this prospectus. 4
RISK FACTORS You should carefully consider the following risk factors and all of the information set forth in this prospectus, as well as the risk factors and information incorporated by reference in this prospectus, before deciding to invest in the common stock. The risks described below and incorporated by reference are not the only ones facing our Company. Additional risks not now known to us or that we currently deem immaterial may also impair our business operations. OUR STOCK PRICE MAY FLUCTUATE SIGNIFICANTLY. The market price of our common stock could fluctuate significantly in response to variations in quarterly operating results and other factors, such as: - changes in our business, operations or prospects; - developments in our relationships with our customers; - announcements of new products or services by us or by our competitors; - announcement or completion of acquisitions by us or by our competitors; - changes in existing or adoption of additional government regulations; - unfavorable or reduced analyst coverage; and - prevailing domestic and international market and economic conditions. In addition, the stock market has experienced significant price fluctuations in recent years. Many companies experienced material fluctuations in their stock price that were unrelated to their operating performance. Broad market fluctuations, general economic conditions and specific conditions in the industry in which we operate may adversely affect the market price of our common stock. LIMITED TRADING VOLUME OF OUR CAPITAL STOCK MAY CONTRIBUTE TO ITS PRICE VOLATILITY. Our common stock is traded on The Nasdaq SmallCap Market. During the five months ended May 31, 2004, the average daily trading volume for our common stock as reported by The Nasdaq SmallCap Market was approximately 130,500 shares. We are uncertain whether a more active trading market in our common stock will develop. In addition, many investment banks no longer find it profitable to provide securities research on micro-cap and small-cap companies. If analysts were to discontinue coverage of our common stock, our trading volume may be further reduced. As a result, relatively small trades may have a significant impact on the market price of our common stock, which could increase the volatility and depress the price of our common stock. FUTURE SALES OF OUR COMMON STOCK MAY CAUSE OUR STOCK PRICE TO DECLINE. In the future, we may sell additional shares of our common stock in public or private offerings, and we may also issue additional shares of our common stock to finance future acquisitions. Shares of our common stock are also available for future sale pursuant to stock options that we have granted to our employees, and in the future 5
we may grant additional stock options and other forms of equity compensation to our employees. Sales of our common stock, or the perception that such sales could occur, may adversely affect prevailing market prices for shares of our common stock and could impair our ability to raise capital through future offerings. WE DEPEND ON KEY PERSONNEL. Our future success will depend in significant part upon the continued service of certain key management and other personnel and our continuing ability to attract and retain highly qualified managerial, technical and sales and marketing personnel. There can be no assurance that we will be able to recruit and retain such personnel. The loss of Bart C. Shuldman, the Company's Chairman of the Board, President and Chief Executive Officer, or the loss of certain groups of key employees, could have a material adverse affect on our results of operations. OUR BUSINESS COULD BE ADVERSELY AFFECTED BY ACTUAL OR THREATENED TERRORIST ATTACKS OR THE RELATED HEIGHTENED SECURITY MEASURES, MILITARY ACTIONS AND OTHER EFFORTS TO COMBAT TERRORISM. Our business could be adversely affected by actual or threatened terrorist attacks or the related heightened security measures, military actions and other efforts to combat terrorism. It is possible that terrorist attacks could be directed at important locations for the gaming industry. Heightened security measures and other efforts to combat terrorism may also have an adverse effect on the gaming industry by reducing tourism. Any of these developments could also negatively affect the general economy and consumer confidence. Any downturn in the economy, or in the gaming industry in particular, could reduce demand for our products and adversely affect our business and results of operations. OUR PROPOSED ACQUISITION OF THE TPG BUSINESS IS SUBJECT TO CERTAIN CONTINGENCIES. Our proposed acquisition of the TPG business is subject to the completion of our due diligence investigation and the negotiation of definitive agreements. We can give no assurance that definitive agreements will be successfully negotiated or, even if they are, that they will contain terms that are identical to those contained in the letter of intent we have signed or that the transaction will be successfully completed. WE FACE BURDENS RELATING TO THE RECENT TREND TOWARD STRICTER CORPORATE GOVERNANCE AND FINANCIAL REPORTING STANDARDS. Recently adopted or new legislation or regulations that follow the trend of imposing stricter corporate governance and financial reporting standards, including compliance with Section 404 of the Sarbanes-Oxley Act of 2002, may lead to an increase in our costs of compliance. A failure to comply with these new laws and regulations may impact market perception of our financial condition and could materially harm our business. Additionally, if the acquisition of the TPG business is successful, our ability to comply with such legislation and regulations may be adversely affected. OUR SUCCESS WILL DEPEND ON OUR ABILITY TO SUSTAIN AND MANAGE GROWTH. As part of our business strategy, we intend to pursue an aggressive growth strategy. Assuming this growth occurs, it will require the expansion of distribution relationships in international markets, the successful development and marketing of new products, expanded customer service and support, an increased number of personnel throughout the Company and the continued implementation and improvement of our operational, financial and management information systems. To the extent that we seek growth through acquisitions, such as the potential acquisition of the TPG business for which we recently signed a letter of intent, our ability to manage our growth will also depend on our ability to integrate businesses that have previously operated independently. We may not be able to achieve this integration without encountering difficulties or experiencing the loss of key employees, customers or suppliers. It may be difficult to design and implement effective financial controls for combined operations and differences in existing controls for each business may result in weaknesses that require remediation when the financial controls and reporting functions are combined. There can be no assurance that we will be able to implement successfully our growth strategy, or that we can successfully manage expanded operations. As the Company expands, we may from time to time experience constraints that will adversely affect our ability to satisfy customer demand in a timely fashion. Failure to manage growth effectively could adversely affect the Company's results of operations and financial condition. 6
WE FACE RISKS ASSOCIATED WITH INTERNATIONAL OPERATIONS. Our international sales, which includes sales by our United Kingdom subsidiary and export sales from our domestic operations, totaled approximately $4,731,000 (approximately 9.1% of net revenues) in fiscal 2003. Most of these sales were in Europe and Latin America. As part of our business strategy, we intend to increase international sales as a percentage of our revenues. International sales are subject to inherent risks, including fluctuations in local economies, fluctuating exchange rates, increased difficulty of inventory management, greater difficulty in accounts receivable collection, costs and risks associated with localizing products for foreign countries, unexpected changes in regulatory requirements, tariffs and other trade barriers and burdens of complying with a variety of foreign laws. There can be no assurance that these factors will not have a material adverse impact on our ability to increase or maintain our international sales or on our results of operations. WE FACE EVOLVING TECHNOLOGY AND CHANGING MARKET REQUIREMENTS. The transaction based printer industry is characterized by evolving technology and changing market requirements. Our future success will depend on our ability to continue to design, develop and manufacture new products and to enhance existing products, reflecting technological evolution and changing market requirements. We anticipate ongoing investment in engineering and product development. WE DO NOT INTEND TO PAY CASH DIVIDENDS. We intend to retain any future earnings for our business and do not anticipate paying any cash dividends in the foreseeable future OUR PREFERRED STOCK RIGHTS PLAN, CERTIFICATE OF INCORPORATION, BY-LAWS AND DELAWARE LAW CONTAIN PROVISIONS MAY HAVE ANTI-TAKEOVER EFFECTS. On December 2, 1997, our Board of Directors declared a distribution of certain rights to purchase shares of our Series A Preferred Stock to the holders of our outstanding common stock. The purpose of this rights plan is to assure fair value in the event of a future unsolicited business combination or similar transaction involving TransAct. If a person or group accumulates or solicits a tender or exchange offer for 15% of our common stock, the rights become exercisable for additional shares of our Series A Preferred Stock. The intent of these rights is to encourage a potential acquirer to negotiate with our Board of Directors to increase the consideration paid for our stock. We are also authorized to issue 5,000,000 shares of undesignated preferred stock, which we may issue without stockholder approval upon such terms as our Board of Directors may determine. We are also subject to the anti-takeover provisions of Section 203 of the Delaware General Corporation Law, which prohibits us from engaging in a "business combination" with an "interested stockholder" for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. In addition, our certificate of incorporation and by-laws contain other provisions that might enable our management to resist a takeover. Our rights plan, Section 203 of the Delaware General Corporation Law and any of these provisions of our certificate of incorporation and by-laws might discourage, delay or prevent a change in control of TransAct or a change in our management. The existence of these provisions could also adversely affect the price that investors might be willing to pay in the future for our common stock. NOTE ON FORWARD-LOOKING STATEMENTS This prospectus contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements generally can be identified by use of statements that include words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" and other words and terms of similar meaning, although not all forward-looking statements contain such words. Statements that describe our 7
objectives, plans or goals are also forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those currently anticipated. Factors that could materially affect these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission (the "SEC") and in this prospectus under the heading "Risk Factors." Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included in this prospectus are made only as of the date of this prospectus, and we undertake no obligation to publicly update these forward-looking statements to reflect new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events might or might not occur. We cannot assure you that projected results or events will be achieved. USE OF PROCEEDS The Company will not receive any proceeds from sales of common stock by the selling stockholders. 8
SELLING STOCKHOLDERS On April 7, 2000, we sold an aggregate of 4,000 shares of our Series B Preferred Stock, which were convertible into shares of our common stock. On March 9, 2004, the holders of Series B Preferred Stock converted all of the outstanding Series B Preferred Stock into the shares of common stock covered by this prospectus. The registration of these shares is required under the terms of a registration rights agreement that we entered into at the time of the sale of the Series B Preferred Stock. We prepared the following table based on the information supplied to us by the selling stockholders named in the table. The selling stockholders may, however, have sold, transferred or otherwise disposed of all or a portion of their shares of common stock since the date on which they provided such information. None of the selling stockholders has held any position with, or has otherwise had a material relationship with, us within the past three years. We do not know when a selling stockholder may offer shares of common stock for sale or in what amounts. The selling stockholders may choose not to sell any of the shares offered by this prospectus. Because the selling stockholders may offer all, some or none of their shares of common stock pursuant to this offering, we cannot estimate the number of shares of common stock that the selling stockholders will hold after completion of the offering. For purposes of the following table, we have assumed that the selling stockholders will sell all of the shares of common stock covered by this prospectus. Except as otherwise set forth below, each selling stockholder has sole voting power over the shares of common stock shown as beneficially owned. NUMBER OF SHARES OF PERCENTAGE OF COMMON STOCK NUMBER OF SHARES OF BENEFICIAL OWNERSHIP NAME OF SELLING BENEFICIALLY OWNED COMMON STOCK BEING AFTER COMPLETION OF STOCKHOLDER BEFORE OFFERING OFFERED OFFERING - ----------------------------------------------------- ------------------- ------------------- -------------------- Janus Investment Fund on behalf of its series Janus Venture Fund 544,567 333,333 2.13% Swiftcurrent Partners, LP 90,000 90,000 * Swiftcurrent Offshore, Ltd. 76,666 76,666 * SLS Investors, LP 44,500 44,500 * SLS Offshore Fund, Ltd. 122,166 122,166 * * Less than one percent 9
DESCRIPTION OF COMMON STOCK The following description of our common stock includes a summary of some of the detailed provisions of our certificate of incorporation, as amended, and by-laws, as amended. These statements do not purport to be complete or to give full effect to the provisions of statutory or common law, and are subject to, and are qualified in their entirety by reference to, the terms of our certificate of incorporation and by-laws. We encourage you to read our certificate of incorporation and by-laws, which have been filed with the SEC and are incorporated by reference in this prospectus, for a more complete description. GENERAL Our authorized capital stock consists of 20,000,000 shares of common stock, par value $0.01 per share, and 5,000,000 shares of preferred stock, $0.01 per share. As of June 17, 2004, we had 9,893,914 shares of common stock outstanding. In addition, as of June 17, 2004, an aggregate of 963,096 shares of our common stock were issuable upon the exercise of outstanding options and 401,412 shares were reserved for issuance under our stock incentive plans. As of June 17, 2004, no shares of our preferred stock were outstanding or reserved for issuance. RIGHTS OF HOLDERS OF OUR COMMON STOCK Stockholders are entitled to one vote for each share of our common stock held of record on all matters on which stockholders are entitled or permitted to vote. Our common stock does not have cumulative voting rights in the election of directors. As a result, holders of a majority of the shares of our common stock voting for the election of directors can elect all the directors standing for election. Subject to preferences that may be applicable to any outstanding shares of our preferred stock designated by the Company's Board of Directors from time to time, holders of our common stock are entitled to receive dividends out of legally available funds when and if declared from time to time by our Board of Directors. In the event of our liquidation, dissolution or winding up, the holders of our common stock will be entitled to share ratably in all assets remaining after payment of liabilities, subject to preferences applicable to shares of our preferred stock, if any, then outstanding. Our common stock has no preemptive, subscription or conversion rights, and there are no redemption or sinking fund provisions in our certificate of incorporation. The outstanding shares of our common stock are fully paid and nonassessable. CLASSIFIED BOARD OF DIRECTORS Our certificate of incorporation provides for our Board of Directors to be divided into three classes, with each class serving a staggered three year term. We believe that a classified board helps to ensure the continuity and stability of the Board of Directors and the Company's business strategies and policies. The classified board structure could have the effect of making the removal of incumbent directors more time consuming and difficult, and, therefore of discouraging a third party from making a tender offer or otherwise attempting to obtain control of the Company, even though such an attempt might be beneficial to the Company and its stockholders. CORPORATE GOVERNANCE PROVISIONS OF OUR BY-LAWS Our by-laws provide that special meetings of stockholders may be called at any time by the Chairman of the Board or President of the Company and shall be called upon the written request of the Board of Directors or of the holders of record shares having a majority of the voting power of the capital stock of the Company. Our by-laws provide that the number of directors will be fixed from time to time by resolution of the Board of Directors. Our Board of Directors currently consists of four (4) directors. 10
SECTION 203 OF THE DELAWARE GENERAL CORPORATION LAW. We are a Delaware corporation that is subject to Section 203 of the Delaware General Corporation Law. Section 203 provides in general that a stockholder acquiring more than 15% of the outstanding voting stock of a corporation subject to Section 203 but less than 85% of such stock may not engage in a Business Combination, as defined in Section 203, with the corporation for a period of three years from the date on which that stockholder became an Interested Stockholder, as defined in Section 203, unless (1) prior to such date the corporation's board of directors approved either the Business Combination or the transaction in which the stockholder became an Interested Stockholder or (2) the Business Combination is approved by the corporation's board of directors and authorized by the holders of at least 66% of the outstanding voting stock of the corporation not owned by the Interested Stockholder. A "Business Combination" includes a merger, asset sale or other transaction resulting in a financial benefit to a stockholder. A Delaware corporation may "opt out" of Section 203 with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or by-laws resulting from amendments approved by holders of at least a majority of a corporation's outstanding voting shares. We have not "opted out" of the provisions of Section 203. LIMITATIONS ON LIABILITY AND INDEMNIFICATION OF OFFICERS AND DIRECTORS Our certificate of incorporation provides that no director will be liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director. Under the Delaware General Corporation Law, liability of a director may not be limited: - - for any breach of the director's duty of loyalty to us or our stockholders, - - for acts or omissions not in good faith or that involve intentional misconduct or knowing violation of law, - - in respect of certain unlawful dividend payments or stock redemptions or repurchases, and - - for any transaction from which the director derives an improper personal benefit. The effect of this provision of our certificate of incorporation is to eliminate our rights and the rights of our stockholders to recover monetary damages against a director for breach of the fiduciary duty of care as a director, including breaches resulting from negligent or grossly negligent behavior, except in the situations described above. This provision does not limit or eliminate our rights or the rights of any stockholder to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director's duty of care. In addition, our certificate of incorporation provides that we will indemnify our directors, officers, employees and agents to the fullest extent permitted by law. We may purchase and maintain insurance or furnish similar protection on behalf of any officer or director against any liability asserted against the officer or director and incurred by the officer or director in such capacity, or arising out of the status, as an officer or director. TRANSFER AGENT AND REGISTRAR The transfer agent and registrar for our common stock is American Stock Transfer & Trust Co. 11
PLAN OF DISTRIBUTION The selling stockholders, or their pledgees, donees, transferees, or any of their successors in interest selling shares received from a named selling stockholder as a gift, partnership distribution or other non-sale-related transfer after the date of this prospectus (all of whom may be selling stockholders), may sell the shares of common stock from time to time after the date of this prospectus on any stock exchange or automated interdealer quotation system on which our common stock is listed, in the over-the-counter market, in privately negotiated transactions or otherwise, at fixed prices that may be changed, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at prices otherwise negotiated. The selling stockholders may sell the shares of common stock by one or more of the following methods: (a) ordinary brokerage transactions (including block trades) and transactions in which the broker solicits purchases; (b) private sales or private transactions; (c) one or more underwritten offerings on a firm commitment or best efforts basis; and (d) a combination of any of these methods of sale or any other legally available means, whether or not described in this prospectus. At the time a particular offering of shares is made hereunder, to the extent required by Rule 424 under the Securities Act of 1933, we will file a prospectus supplement setting forth: (a) the number of shares involved; (b) the names of any underwriters, dealers or agents; (c) the price at which the shares are being offered or purchased; (d) any commissions or discounts or concessions allowed to broker-dealers; (e) any discounts, commissions or other items constituting compensation from the selling shareholder; and (f) any other facts material to the transaction. In connection with sales of the shares of common stock, the selling stockholders may enter into hedging transactions with broker-dealers only to the extent permitted by the Securities Act and any applicable securities laws of any state of the United States. These broker-dealers may in turn engage in short sales of the shares of common stock and deliver shares of common stock to close out such short positions, or loan or pledge shares of common stock to broker-dealers that may in turn sell such securities. Any selling stockholder may pledge or grant a security interest in some or all of the shares of common stock that it owns and, if it defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time pursuant to this prospectus. The selling stockholders may also transfer and donate shares of common stock in other circumstances, in which case the transferees, donees, pledgees or other successors in interest will be selling stockholders for the purposes of this prospectus. To our knowledge, there are currently no plans, arrangements or understanding between any selling stockholders and any underwriters, broker-dealer or agent regarding the sale of the shares of common stock by the selling stockholders. 12
On April 7, 2000, we sold an aggregate of 4,000 shares of our Series B Preferred Stock, which were convertible into shares of our common stock. In April, 2004, the holders of Series B Preferred Stock converted all of the outstanding Series B Preferred Stock into the shares of common stock covered by this prospectus. The registration of these shares is required under the terms of a registration rights agreement that we entered into at the time of the sale of the Series B Preferred Stock. Pursuant to the registration rights agreement, we have agreed to indemnify in certain circumstances the selling stockholders and their affiliates against certain liabilities, including liabilities under the Securities Act. The selling stockholders have agreed to indemnify us in certain circumstances against certain liabilities, including liabilities under the Securities Act. We have also agreed to pay certain expenses in connection with this offering, including, in certain circumstances, the fees and expenses of counsel to the selling stockholders, but not including underwriting discounts, concessions, commissions or fees of the selling stockholders. The selling stockholders and any other person participating in such distribution will be subject to the Exchange Act rules, including, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any such other person. In addition, Regulation M of the Exchange Act may restrict the ability of any person engaged in the distribution of the shares of common stock to engage in market-making activities with respect to the shares of common stock being distributed for a period of up to five business days prior to the commencement of distribution. This may affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares of common stock. We may suspend the use of this prospectus by the selling stockholder under certain circumstances. Any common stock sold by a selling stockholder pursuant to a prospectus supplement will be listed on The Nasdaq SmallCap Market, subject to official notice of issuance. LEGAL MATTERS The validity of the shares of common stock will be passed upon for us by Shipman & Goodwin LLP. EXPERTS The financial statements incorporated in this prospectus by reference to the Annual Report on Form 10-K for the year ended December 31, 2003 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, our independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. 13
WHERE YOU CAN FIND MORE INFORMATION We have filed with the SEC a registration statement on Form S-3 with respect to the common stock offered in this prospectus. This prospectus does not contain all of the information set forth in the registration statement and the exhibits to that registration statement. For further information with respect to us and the common stock, we refer you to the registration statement and its exhibits. We also file annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any document we file at the Public Reference Room of the SEC, 450 Fifth Street, N.W., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. Our SEC filings are also available to the public from the SEC's website at http://www.sec.gov and on our website at http://www.transact-tech.com. With the exception of the documents we file with the SEC, the information contained on our website is not incorporated by reference in this prospectus and you should not consider it a part of this prospectus. INCORPORATION BY REFERENCE We are incorporating by reference the information that we file with the SEC, which means that we are disclosing important information to you in those documents. The information incorporated by reference is an important part of this prospectus, and the information that we subsequently file with the SEC will automatically update and supercede information in this prospectus and in our other filings with the SEC. We incorporate by reference the documents listed below, which we have already filed with the SEC, and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934. We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not deemed "filed" with the SEC, including any information furnished pursuant to Items 9 or 12 of any Current Report on Form 8-K. - - Annual Report on Form 10-K for the year ended December 31, 2003, filed on March 30, 2004; - - Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2004, filed on May 12, 2004; and - - Current Report on Form 8-K, filed on May 3, 2004. You may request a copy of any of our filings with the SEC, or any of the agreements or other documents that constitute exhibits to those filings, at no cost, by writing or telephoning us at the following address or phone number: TransAct Technologies Incorporated c/o Investor Relations 7 Laser Lane Wallingford, Connecticut 06492 Telephone: (203) 269-1198 YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE IN THIS PROSPECTUS. WE HAVE NOT AUTHORIZED ANYONE ELSE TO PROVIDE YOU WITH ADDITIONAL OR DIFFERENT INFORMATION. YOU SHOULD NOT ASSUME THAT THE INFORMATION IN THIS PROSPECTUS IS ACCURATE AS OF ANY DATE OTHER THAN THE DATE ON THE FRONT COVER OF THIS PROSPECTUS. 14
PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item 14. Other Expenses of Issuance and Distribution The following statement sets forth the estimated amounts of expenses, other than underwriting discounts, to be borne by the registrant in connection with the distribution of the offered securities. SEC registration fee................................. $ 2,588.47 Accounting fees and expenses......................... 25,000.00 Legal fees and expenses.............................. 50,000.00 Miscellaneous expenses............................... 12,000.00 ----------- Total expenses....................................... $ 89,588.47 =========== Item 15. Indemnification of Directors and Officers. Section 145(a) of the Delaware General Corporation Law provides, in general, that a corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because the person is or was a director or officer of the corporation. Such indemnity may be against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and if, with respect to any criminal action or proceeding, the person did not have reasonable cause to believe the person's conduct was unlawful. Section 145(b) of the Delaware General Corporation Law provides, in general, that a corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was a director or officer of the corporation, against any expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnify for such expenses which the Court of Chancery or such other court shall deem proper. Section 145(g) of the Delaware General Corporation Law provides, in general, that a corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation against any liability asserted against the person in any such capacity, or arising out of the person's status as such, whether or not the corporation would have the power to indemnify the person against such liability under the provisions of the law. II-1
The certificate of incorporation, as amended, of the registrant provides that (a) the registrant shall indemnify to the full extent permitted by law any person made, or threatened to be made, a party to any claim, action, suit or proceeding (whether civil, criminal, administrative or investigative) by reason of the fact that he is or was a director, officer or employee of the registrant serving at the registrant's request as a director or officer of another corporation or of a partnership, joint venture, trust or other enterprise and (b) the registrant shall pay the expenses, including attorney's fees, incurred by a director or officer in defending or investigating a threatened or pending claim, action, suit or proceeding, in advance of the final disposition of such claim, action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount by the registrant. The certificate of incorporation also provides that, to the extent permitted by law, the directors of the registrant shall have no liability to the registrant or its stockholder for monetary damages for breach of fiduciary duty as a director. The registrant maintains policies of insurance under which the registrant's directors and officers are insured, within the limits and subject to the limitations of the policies, against certain expenses in connection with the defense of actions, suits or proceedings, and certain liabilities which might be imposed as a result of such actions, suits or proceedings, to which they are parties by reason of being or having been such directors or officers. The foregoing statements are subject to the detailed provisions of Section 145 of the Delaware General Corporation Law and the certificate of incorporation and by-laws of TransAct Technologies Incorporated. Item 16. Exhibits 3.1(a) -- Certificate of Incorporation of the Company, filed with the Delaware Secretary of State on June 17, 1996 (2) 3.1(b) -- Certificate of Amendment of Certificate of Incorporation of the Company, filed with the Delaware Secretary of State on June 4, 1997 (3) 3.1(c) -- Certificate of Designation, Series A Preferred Stock, filed with the Delaware Secretary of State on December 2, 1997 (4) 3.2 -- Amended and Restated By-laws of the Company (6) 4.1 -- Specimen Common Stock Certificate (2) 4.2 -- Amended and Restated Rights Agreement between TransAct and American Stock Transfer & Trust Company, dated February 16, 1998 (5) 5.1 -- Opinion of Shipman & Goodwin LLP (1) 23.1 -- Consent of PricewaterhouseCoopers LLP (1) 23.2 -- Consent of Shipman & Goodwin LLP (included in Exhibit 5.1) 24.1 -- Power of Attorney of Charles A. Dill (1) 24.2 -- Power of Attorney of Thomas R. Schwarz (1) 24.3 -- Power of Attorney of Graham Y. Tanaka (1) 24.4 -- Power of Attorney of Bart C. Shuldman (1) 24.5 -- Power of Attorney of Steven A. DeMartino (1) - ------------- (1) These exhibits are filed herewith. (2) These exhibits, which were previously filed with the Company's Registration Statement on Form S-1 (No. 333-06895), are incorporated by reference. (3) These exhibits, which were previously filed with the Company's Annual Report on Form 10-K for the year ended December 31, 1997 (Commission File No. 000-21121), are incorporated by reference. (4) This exhibit, which was previously filed with the Company's Current Report on Form 8-K, filed December 2, 1997 (Commission File No. 000-21121), is incorporated by reference. II-2
(5) This exhibit, which was previously filed with the Company's Current Report on Form 8-K, filed February 18, 1999 (Commission File No. 000-21121), is incorporated by reference. (6) This exhibits, which was previously filed with the Company's Annual Report on Form 10-K for the year ended December 31, 1998 (Commission File No. 000-21121), is incorporated by reference. Item 17. Undertakings A. Undertaking Regarding Rule 415 Offering The undersigned registrant hereby undertakes: 1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information in the registration statement. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; Provided, however, that paragraphs (i) and (ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement. (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. B. Undertaking Regarding Filings Incorporating Subsequent Exchange Act Documents by Reference The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the II-3
Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. C. Undertaking in Respect of Indemnification Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 15 above, or otherwise, the registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such officer, director or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. II-4
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Wallingford, State of Connecticut, on June 18, 2004. TRANSACT TECHNOLOGIES INCORPORATED By: /s/ Bart C. Shuldman -------------------------------------- Name: Bart C. Shuldman Title: Chairman of the Board, President and Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed on June 18, 2004 by the following persons in the capacities indicated. Signatures Title ---------- ----- /s/ Bart C. Shuldman Chairman of the Board, President, - -------------------------- Chief Executive Officer and Director Bart C. Shuldman (Principal Executive Officer) /s/ Steven A. DeMartino Executive Vice President, Chief Financial Officer - -------------------------- Officer, Treasurer and Secretary Steven A. DeMartino (Principal Financial Officer and Principal Accounting Officer) /s/ Charles A. Dill* - -------------------------- Director Charles A. Dill /s/ Thomas R. Schwarz* - -------------------------- Director Thomas R. Schwartz /s/ Graham Y. Tanaka* - -------------------------- Director Graham Y. Tanaka *By: /s/ Steven A. DeMartino ----------------------------- (Steven A. DeMartino Attorney-in-Fact) II-5
EXHIBITS 3.1(a) -- Certificate of Incorporation of the Company, filed with the Delaware Secretary of State on June 17, 1996 (2) 3.1(b) -- Certificate of Amendment of Certificate of Incorporation of the Company, filed with the Delaware Secretary of State on June 4, 1997 (3) 3.1(c) -- Certificate of Designation, Series A Preferred Stock, filed with the Delaware Secretary of State on December 2, 1997 (4) 3.2 -- Amended and Restated By-laws of the Company (6) 4.1 -- Specimen Common Stock Certificate (2) 4.2 -- Amended and Restated Rights Agreement between TransAct and American Stock Transfer & Trust Company, dated February 16, 1998 (5) 5.1 -- Opinion of Shipman & Goodwin LLP (1) 23.1 -- Consent of PricewaterhouseCoopers LLP (1) 23.2 -- Consent of Shipman & Goodwin LLP (included in Exhibit 5.1) 24.1 -- Power of Attorney of Charles A. Dill (1) 24.2 -- Power of Attorney of Thomas R. Schwarz (1) 24.3 -- Power of Attorney of Graham Y. Tanaka (1) 24.4 -- Power of Attorney of Bart C. Shuldman (1) 24.5 -- Power of Attorney of Steven A. DeMartino (1) - ------------------ (1) These exhibits are filed herewith. (2) These exhibits, which were previously filed with the Company's Registration Statement on Form S-1 (No. 333-06895), are incorporated by reference. (3) These exhibits, which were previously filed with the Company's Annual Report on Form 10-K for the year ended December 31, 1997 (Commission File No. 000-21121), are incorporated by reference. (4) This exhibit, which was previously filed with the Company's Current Report on Form 8-K, filed December 2, 1997 (Commission File No. 000-21121), is incorporated by reference. (5) This exhibit, which was previously filed with the Company's Current Report on Form 8-K, filed February 18, 1999 (Commission File No. 000-21121), is incorporated by reference. (6) This exhibit, which was previously filed with the Company's Annual Report on Form 10-K for the year ended December 31, 1998 (Commission File No. 000-21121), is incorporated by reference. II-6
EXHIBIT 5.1 (LETTERHEAD OF SHIPMAN & GOODWIN LLP) June 18, 2004 TransAct Technologies Incorporated 7 Laser Lane Wallingford, Connecticut 06492 Re: Registration Statement on Form S-3 Dear Sir or Madam: We have acted as counsel to TransAct Technologies Incorporated, a Delaware corporation (the "Company"), in connection with the filing of a Registration Statement on Form S-3 (the "Registration Statement") to register an aggregate of 666,665 shares (the "Shares") of the Company's common stock, par value $0.01 per share ("Common Stock"), pursuant to the Securities Act of 1933, as amended. As such counsel, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary for the purpose of rendering this opinion. In our examinations, we have assumed the genuineness of all signatures and the authenticity of all documents submitted to us as copies. We do not purport to be experts in, or to express any opinion herein concerning, the law of any jurisdiction other than the State of Connecticut, the United States of America and the State of Delaware (but only insofar as set forth in the General Corporation Law of the State of Delaware.) Based on the foregoing, we are of the opinion that the Shares have been duly authorized and validly issued, and are fully paid and nonassessable. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement being filed with the Securities and Exchange Commission. In giving such consent, we do not thereby admit that we are within the category of persons whose consent is required by Section 7 of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. Very truly yours, /s/ Shipman & Goodwin LLP II-7
EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated February 26, 2004, except for Note 21, which is as of March 4, 2004, relating to the financial statements, which appears in TransAct Technologies Incorporated's Annual Report on Form 10-K for the year ended December 31, 2003. We also consent to the references to us under the headings "Experts" and "Selected Consolidated Financial Data" in such Registration Statement. /s/ PricewaterhouseCoopers LLP PRICEWATERHOUSECOOPERS LLP Hartford, Connecticut June 18, 2004 II-8
EXHIBIT 24.1 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Bart C. Shuldman and Steven A. DeMartino, and each of them acting alone, his true and lawful attorneys-in-fact, and agents, with full power of substitution and revocation, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-3 (the "Registration Statement") of TransAct Technologies Incorporated (the "Company") relating to the common stock of the Company and any and all amendments to the Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully as to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Dated: June 18, 2004 /s/ Charles A. Dill --------------------------- Charles A. Dill II-9
EXHIBIT 24.2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Bart C. Shuldman and Steven A. DeMartino, and each of them acting alone, his true and lawful attorneys-in-fact, and agents, with full power of substitution and revocation, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-3 (the "Registration Statement") of TransAct Technologies Incorporated (the "Company") relating to the common stock of the Company and any and all amendments to the Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully as to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Dated: June 18, 2004 /s/ Thomas R. Schwarz ------------------------------- Thomas R. Schwarz II-10
EXHIBIT 24.3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Bart C. Shuldman and Steven A. DeMartino, and each of them acting alone, his true and lawful attorneys-in-fact, and agents, with full power of substitution and revocation, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-3 (the "Registration Statement") of TransAct Technologies Incorporated (the "Company") relating to the common stock of the Company and any and all amendments to the Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully as to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Dated: June 18, 2004 /s/ Graham Y. Tanaka ------------------------------- Graham Y. Tanaka II-11
EXHIBIT 24.4 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Steven A. DeMartino his true and lawful attorney-in-fact, and agent, with full power of substitution and revocation, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-3 (the "Registration Statement") of TransAct Technologies Incorporated (the "Company") relating to the common stock of the Company and any and all amendments to the Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully as to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Dated: June 18, 2004 /s/ Bart C. Shuldman ------------------------------- Bart C. Shuldman II-12
EXHIBIT 24.5 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Bart C. Shuldman his true and lawful attorney-in-fact, and agent, with full power of substitution and revocation, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-3 (the "Registration Statement") of TransAct Technologies Incorporated (the "Company") relating to the common stock of the Company and any and all amendments to the Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully as to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Dated: June 18, 2004 /s/ Steven A. DeMartino ------------------------------- Steven A. DeMartino II-13